dry%20eye%20syndrome
DRY EYE SYNDROME

Dry eye syndrome is a clinical condition wherein the patient experiences ocular and conjunctival irritation due to decreased tear production and/or excessive tear evaporation.
It is associated with increased osmolarity of the tear film and inflammation of the ocular surface.

Goal of treatments are to relieve symptoms of patients, to improve visual acuity & quality of life of patients, to restore ocular surface & tear film to normal homeostatic state and to correct the underlying defect.

Drug Information

Indication: Temporary relief of discomfort due to minor eye irritation from exposure to wind, sun or other irritants. Prot...

GenTeal Gel
carbomer + hypromellose

Indication: Lubricant eye gel for wearers of all types of contact lenses.

Indication: Keratoconjunctival epithelial disorders resulting from Sjogren's & Sicca syndrome (dry eye) & extrinsi...

Indication: OA of the knee, periarthritis of the shoulder.

Indication: Management of acute & chronic anterior uveitis, iridocyclitis, iritis & cyclitis, herpes zoster ophtha...

Tears Naturale Free
dextran 70 + hydroxypropyl methylcellulose

Indication: Relief in both mucin & aqueous deficient dry eye syndromes & symptoms of severe keratoconjunctivitis s...

Tears Naturale II
dextran 70 + hydroxypropyl methylcellulose

Indication: Relief of burning & irritation due to dryness in eyes or exposure to wind or sun. Protectant against furth...

Indication: Vismed/Vismed Multi Lubrication of the eyes in case of dryness, burning sensation & ocular fatigue. Vismed...

1  /  4
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
09 Jan 2020
Acute ischaemic stroke patients who are current or recent smokers are at greater odds of having unfavourable functional outcomes 3 months after the index event, a study has found.
Stephen Padilla, 2 days ago
Brodalumab has exhibited long-term efficacy and consistent safety profile for more than 2 years in the treatment of patients with psoriasis, results of the phase III AMAGINE-2 trial show.
3 days ago
Anaemia increases mortality risk in heart failure (HF) patients across the ejection fraction (EF) spectrum, a recent study has found. The effect appears to be stronger in preserved (HFpEF) and midrange (HFmrEF) than in reduced (HFrEF) EF disease.